Развитие тяжелой остеомаляции после билиопанкреотического шунтирования по поводу морбидного ожирения: клинический случай

Билиопанкреатическое шунтирование (БПШ) - одна из наиболее эффективных бариатрических операций при морбидном ожирении. Однако помимо стойкого снижения массы тела и нивелирования ряда заболеваний, ассоциированных с ожирением, после оперативного лечения существует риск костно-метаболических нарушений. Описан клинический случай остеомаляции, развившейся в отдаленном периоде после БПШ на фоне отсутствия регулярного приема лекарственных препаратов и медицинского наблюдения.

билиопанкреатическое шунтирование, остеомаляция, вторичный гиперпаратиреоз, витамин D, ожирение

1. Dixon J.B., Pories W.J., O'Brien P.E. et al. Surgery as an effective early intervention for diabesity: why the reluctanceα Diabetes Care 2005; 28: 472-474.

2. Santry H.P., Gillen D.L., Lauderdale D.S. Trends in bariatric surgical procedures. J Am Med Ass 2005; 294: 1909-1917.

3. de Prisco C., Levine S.N. Metabolic bone disease after gastric bypass surgery for obesity. Am J Med Sci 2005; 329: 57-61.

4. Goode L.R., Brolin R.E., Chowdhury H.A. et al. Bone and gastric bypass surgery: effects of dietary calcium and vitamin D. Obes Res 2004; 12: 40-47.

5. Eddy L. Metabolic bone disease after gastrectomy. Am J Med 1971; 50: 4: 442-449.

6. Atreja A., Abacan C., Licata A. A 51-year-old woman with debilitating cramps 12 years after bariatric surgery. Cleveland Clin J Med 2003; 70: 5: 417-426.

7. Collazo-Clavell M.L, Jimenez A., Hodgson S.F. et al. Osteomalacia after Roux-en-Y gastric bypass. Endocrine Pract 2004; 10: 3: 287-288.

8. Goldner S., O'Dorisio T.M., Dillon J.S. et al. Severemetabolic bone disease as a long-termcomplication of obesity surgery. Obes Surg 2002; 12: 685-692.

9. Haria D.M., Sibonga J.D., Taylor H.C. Hypocalcemia, hypovitaminosis D osteopathy, osteopenia, and secondary hyperparathyroidism 32 years after jejunoileal bypass. Endocrine Pract 2005; 11: 5: 335-340.

10. Parikh S.J., Edelman M., Uwaifo G.I. et al. Gastric bypass surgery for morbid obesity leads to an increase in bone turnover and a decrease in bone mass. J Clin Endocrinol Metabol 2004; 89: 1196-1199.

11. Williams S.E., Licata A.A. Severemetabolic bone disease in a 76-year-old woman thirty-three years after bariatric surgery. J Clin Densitometry 2008; 11: 3: 459.

12. Hamoui N., Kim K., Anthone G. et al. The significance of elevated levels of parathyroid hormone in patients with morbid obesity before and after bariatric surgery. Arch Surg 2003; 138: 891-897.

13. Crowley L.V., Seay J., Mullin G. Late effects of gastric bypass for obesity. Am J Gastroenterol 1984; 79: 850-860.

14. Friedman J.E., Dallal R.M., Lord J.L. Gouty attacks occur frequently in postoperative gastric bypass patients. Surg Obes Relat Dis 2008; 4: 11-13.

15. Ott M.T., Fanti P., Malluche H.H. et al. Biochemical evidence of metabolic bone disease in women following Roux-Y gastric bypass for morbid obesity. Obes Surg 1992; 2: 341-348.

16. Pugnale N., Giusti V., Suter M. et al. Bone metabolism and risk of secondary hyperparathyroidism 12 months after gastric banding in obese premenopausal women. Int J Obes Relat Metab Dis 2003; 27: 110-116.

17. Shaker J.L., Norton A.J., Woods M.F. et al. Secondary hyperparathyroidism and osteopenia in women following gastric exclusion surgery for obesity. Osteopor Int 1991; 1: 177-181.

18. Bloomberg R.D., Fleishman A., Nalle J.E. et al. Nutritional deficiencies following bariatric surgery: what have we learned? Obes Surg 2005; 15: 145-154.

19. Brolin R.E., LaMarca L.B., Kenler H.A. et al. Malabsorptive gastric bypass in patients with superobesity. J Gastrointest Surg 2002; 6: 195-205.

20. Dolan K., Hatzifotis M., Newbury L. et al. Acomparison of laparoscopic adjustable gastric banding and biliopancreatic diversion in superobesity. Obes Surg 2004; 14: 165-169.

21. Newbury L., Dolan K., Hatzifotis M. et al. Calcium and vitamin D depletion and elevated parathyroid hormone following biliopancreatic diversion. Obes Surg 2003; 13: 893-895.

22. Slater G.H., Ren C.J., Siegel N. et al. Serum fat soluble vitamin deficiency and abnormal calcium metabolism after malabsorptive bariatric surgery. J Gastrointest Surg 2004; 8: 48-55.

23. Balsa J.A., Botella-Carretero J.I., Peromingo R. et al. Role of calcium malabsorption in the development of secondary hyperparathyroidism after biliopancreatic diversion. J Endocrinol Invest 2008; 31: 845-850.

24. Carlin A.M., Rao D.S., Yager K.M. et al. Effect of gastric bypass surgery on vitamin D nutritional status. Surg Obes Relat Dis 2006; 2: 638-642.

25. Diniz M. de F., Diniz M.T., Sanches S.R. et al. Elevated serum parathormone after Roux-en-Y gastric bypass. Obes Surg 2004; 14: 1222-1226.

26. Johnson J.M., Maher J.W., DeMaria E.J. et al. The Long-term Effects of Gastric Bypass on Vitamin D Metabolism. Ann Surg 2006; 243: 701-705.

27. Sanchez-Hernandez J., Ybarra J., Gich I. et al. Effects of bariatric surgery on vitamin D status and secondary hyperparathyroidism: a prospective study. Obes Res 2005; 15: 1389-1395.

28. Manco M., Calvani M., Nanni G. et al. Low 25-hydroxyvitamin D does not affect insulin sensitivity in obesity after bariatric surgery. Obes Res 2005; 13: 1692-700.

29. Youssef Y., Richards W.O., Sekhar N.A. et al. Risk of secondary hyperparathyroidism after laparoscopic gastric bypass surgery in obese women. Surg Endosc 2007; 21: 1393-1396.

30. Kamycheva E., Sundsfjord J., Jorde R. Serum parathyroid hormone level is associated with body mass index. The 5th Tromso study. Eur J Endocrinol 2004; 151: 167-172.

31. Puzziferri N., Blankenship J., Wolfe B.M. Surgical treatment of obesity. Endocrine 2006; 29: 1: 11-19.

32. Blake G.M., Fogelman I. How important are BMD accuracy errors for the clinical interpretation of DXA scans? J Bone Min Res 2008; 23: 4: 457-462.

33. Carlin A.M., Rao D.S., Meslemani A.M. et al. Prevalenceof vitamin D depletion among morbidly obese patients seeking gastric bypass surgery. Surg Obes Relat Dis 2006; 2: 2: 98-103.

34. Duffey B.G., Pedro R.N., Makhlouf A. et al. Roux-en-Y gastric bypass is associated with early increased risk for development of calcium oxalate nephrolithiasis. J Am Coll Surg 2008; 206: 6: 1145-1153.

35. Sinha M.K., Collazo-Clavell M.L, Rule A. et al. Hyperoxaluric nephrolithiasis is a complication of Roux-en-Y gastric bypass surgery. Kidney Int 2007; 72: 1: 100-107.

36. Brethauer S.A., Chand B., Schauer P.R. Risks andbenefits of bariatric surgery: current evidence. Clev Clin J Med 2006; 73: 11: 993-1007.

37. Hensrud D.D., McMahon M.M. Bariatric surgery in adults with extreme (not morbid) obesity. Mayo Clin Proceedings 2006; 81: Suppl 10: S3-S4.

38. Mason M.E., Jalagani H., Vinik A.I. Metabolic complications of bariatric surgery: diagnosis andmanagement issues. Gastroent Clin North Am 2005; 34: 1: 25-33.

39. McGlinch B.P., Que F.G., Nelson J.L. et al. Perioperative care of patients undergoing bariatric surgery. Mayo Clin Proceedings 2006; 81: 10: S25-S33.

40. Mechanick J.I., Kushner R.F., Sugerman H.J. et al. AACE/TOS/ASMBS Guidelines. Surg Obes Relat Dis 2008; 4: S109-S184.

41. Cannell J., Hollis B. Use of vitamin D in clinical practice. Alternat Med Rev 2008; 13: 6-20.

42. Cannell J., Hollis B., Zasloff M. et al. Diagnosis and treatment of vitamin D deficiency. Exp Opin Pharmacother 2008; 9: 107-118.

43. Heber D., Greenway F.L., Kaplan L.M. et al. Endocrine and Nutritional Management of the Post-Bariatric Surgery Patient: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2010; 95: 11: 4823-4843.